Wu Zhuzhu, Bian Yifei, Chu Tianjiao, Wang Yuman, Man Shuai, Song Yongmei, Wang Zhenguo
Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.
Institute for Literature and Culture of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2022 Dec 15;13:1028647. doi: 10.3389/fphar.2022.1028647. eCollection 2022.
The incidence of melanoma has increased rapidly over the past few decades, with mortality accounting for more than 75% of all skin cancers. The high metastatic potential of Melanoma is an essential factor in its high mortality. Vascular angiogenic system has been proved to be crucial for the metastasis of melanoma. An in-depth understanding of angiogenesis will be of great benefit to melanoma treatment and may promote the development of melanoma therapies. This review summarizes the recent advances and challenges of anti-angiogenic agents, including monoclonal antibodies, tyrosine kinase inhibitors, human recombinant Endostatin, and traditional Chinese herbal medicine. We hope to provide a better understanding of the mechanisms, clinical research progress, and future research directions of melanoma.
在过去几十年中,黑色素瘤的发病率迅速上升,其死亡率占所有皮肤癌的75%以上。黑色素瘤的高转移潜能是其高死亡率的一个重要因素。血管生成系统已被证明对黑色素瘤的转移至关重要。深入了解血管生成将对黑色素瘤的治疗大有裨益,并可能推动黑色素瘤治疗方法的发展。本文综述了抗血管生成药物的最新进展和挑战,包括单克隆抗体、酪氨酸激酶抑制剂、重组人内皮抑素和传统中药。我们希望能更好地理解黑色素瘤的发病机制、临床研究进展及未来研究方向。